Skip to search formSkip to main contentSkip to account menu

AD 32

Known as: AD-32 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

valrubicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Effects of N-trifluoroacetyladriamycin-14-valerate (AD-32) on human bladder tumor cell lines
SummaryWe have compared the in vitro activity of N-trifluoroacetyladriamycin-14-valerate (AD-32) and doxorubicin hydrochloride… 
1996
1996
Phase 1 trial of intraperitoneal AD-32 in gynecologic malignancies.
AD-32 (N-trifluoroacetyladriamycin-14-valerate), an analogue of doxorubicin, was examined for intraperitoneal (ip) administration… 
Highly Cited
1993
Highly Cited
1993
Sterilization of Liposomes by Heat Treatment
Autoclaving of liposomes composed of egg phospholipids or saturated phospholipids, the latter sometimes combined with cholesterol… 
1987
1987
Cytotoxicity and differentiating actions of adriamycin in WEHI-3B D+ leukemia cells.
The monomyelocytic leukemia WEHI-3B D+ can be induced to differentiate into mature granulocytes in suspension culture when… 
1985
1985
Embryotoxic effects of doxorubicin and N-trifluoroacetyladriamycin-14-valerate (AD-32).
Anthracyclines are mutagenic, carcinogenic, and also cardiotoxic. Concern has been shown over the use of anthracycline anticancer… 
1984
1984
Comparative microscopic study of cardiotoxicity and skin toxicity of anthracycline analogs.
Golden hamsters were submitted, three times a week during 4 weeks, to i.p. administration of an antracenedione, mitoxantrone (MTX… 
1983
1983
Correlation of drug sensitivity on human colon adenocarcinoma cells grown in soft agar and in athymic mice
A well‐differentiated colorectal tumor T 219 which grows as a xenograft in athymic mice (human‐tumor‐nude‐mouse system) and forms… 
1982
1982
Adriamycin-induced compaction of isolated chromatin.
1980
1980
N-trifluoroacetyladriamycin-14-valerate and adriamycin induced DNA damage in the RPMI-6410 human lymphoblastoid cell line.
The adriamycin- and N-trifluoroacetyladriamycin-14-valerate (AD-32) induced DNA cross-linking and breakage in human RPMI-6410… 
1979
1979
Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analog.
N-Trifluoroacetyladriamycin-14-valerate (AD-32) is superior to Adriamycin in murine L1210 and P388 leukemias and in a number of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)